| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1806 | 2018 |
| Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 1477 | 2014 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10, 1-10, 2012 | 951 | 2012 |
| Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. HG Wang, T Miyashita, S Takayama, T Sato, T Torigoe, S Krajewski, ... Oncogene 9 (9), 2751-2756, 1994 | 348 | 1994 |
| Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer H Hariu, Y Hirohashi, T Torigoe, H Asanuma, M Hariu, Y Tamura, K Aketa, ... Clinical cancer research 11 (3), 1000-1009, 2005 | 276 | 2005 |
| Detection of anti-livin antibody in gastrointestinal cancer patients A Yagihashi, K Asanuma, N Tsuji, T Torigoe, N Sato, K Hirata, ... Clinical chemistry 49 (7), 1206-1208, 2003 | 274 | 2003 |
| An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin Y Hirohashi, T Torigoe, A Maeda, Y Nabeta, K Kamiguchi, T Sato, J Yoda, ... Clinical cancer research 8 (6), 1731-1739, 2002 | 255 | 2002 |
| Identification of HLA-A2-or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma H Komori, T Nakatsura, S Senju, Y Yoshitake, Y Motomura, Y Ikuta, ... Clinical Cancer Research 12 (9), 2689-2697, 2006 | 244 | 2006 |
| Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT … H Asanuma, T Torigoe, K Kamiguchi, Y Hirohashi, T Ohmura, K Hirata, ... Cancer research 65 (23), 11018-11025, 2005 | 240 | 2005 |
| RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated A Tanabe, K Tanikawa, M Tsunetomi, K Takai, H Ikeda, J Konno, ... Cancer letters 376 (1), 34-42, 2016 | 239 | 2016 |
| Effects of p56lck Deficiency on the Growth and Cytolytic Effector Function of an Interleukin-2-Dependent Cytotoxic T-Cell Line L Karnitz, SL Sutor, T Torigoe, JC Reed, MP Bell, DJ Mckean, PJ Leibson, ... Molecular and cellular biology 12 (10), 4521-4530, 1992 | 238 | 1992 |
| Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer T Tsuruma, F Hata, T Torigoe, T Furuhata, S Idenoue, T Kurotaki, ... Journal of translational medicine 2, 1-11, 2004 | 236 | 2004 |
| Preferential expression of cancer/testis genes in cancer stem‐like cells: proposal of a novel sub‐category, cancer/testis/stem gene R Yamada, A Takahashi, T Torigoe, R Morita, Y Tamura, T Tsukahara, ... Tissue antigens 81 (6), 428-434, 2013 | 226 | 2013 |
| CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection N Yamada, S Oizumi, E Kikuchi, N Shinagawa, J Konishi-Sakakibara, ... Cancer immunology, immunotherapy 59, 1543-1549, 2010 | 196 | 2010 |
| Detection of autoantibodies to livin and survivin in Sera from lung cancer patients A Yagihashi, K Asanuma, D Kobayashi, N Tsuji, Y Shijubo, S Abe, ... Lung cancer 48 (2), 217-221, 2005 | 193 | 2005 |
| A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins S Idenoue, Y Hirohashi, T Torigoe, Y Sato, Y Tamura, H Hariu, ... Clinical cancer research 11 (4), 1474-1482, 2005 | 183 | 2005 |
| Detection of autoantibodies to survivin and livin in sera from patients with breast cancer A Yagihashi, T Ohmura, K Asanuma, D Kobayashi, N Tsuji, T Torigoe, ... Clinica chimica acta 362 (1-2), 125-130, 2005 | 178 | 2005 |
| Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5 T Tsukahara, S Kawaguchi, T Torigoe, H Asanuma, E Nakazawa, ... Cancer science 97 (12), 1374-1380, 2006 | 170 | 2006 |
| Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines T Torigoe, R O'Connor, D Santoli, JC Reed | 164 | 1992 |
| Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells S Inoda, Y Hirohashi, T Torigoe, R Morita, A Takahashi, H Asanuma, ... The American journal of pathology 178 (4), 1805-1813, 2011 | 162 | 2011 |
